Selected research
Industry Research
Gatifloxacin Industry Research Report 2026
Market perspective
The global Gatifloxacin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gatifloxacin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gatifloxacin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gatifloxacin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gatifloxacin include Teva Pharmaceuticals, Sandoz, Mylan, Pacific Pharma, Lupin Pharmaceuticals, Hi Tech Pharmacal, Bristol-Myers Squibb, Apotex and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gatifloxacin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gatifloxacin Market by Company
Teva Pharmaceuticals
Sandoz
Mylan
Pacific Pharma
Lupin Pharmaceuticals
Hi Tech Pharmacal
Bristol-Myers Squibb
Apotex
Allergan
Gatifloxacin Segment by Type
Capsule
Tablet
Aqueous Solution
Others
Gatifloxacin Segment by Application
Synthetic Antibacterial
Ophthalmic Medicine
Other
Gatifloxacin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gatifloxacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gatifloxacin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gatifloxacin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gatifloxacin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gatifloxacin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gatifloxacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Aqueous Solution
- Others
Applications
- Synthetic Antibacterial
- Ophthalmic Medicine
- Other
Companies covered
- Teva Pharmaceuticals
- Sandoz
- Mylan
- Pacific Pharma
- Lupin Pharmaceuticals
- Hi Tech Pharmacal
- Bristol-Myers Squibb
- Apotex
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Gatifloxacin Market Size (2021-2032)
- 2.2.2 Global Gatifloxacin Sales (2021-2032)
- 2.2.3 Global Gatifloxacin Market Average Price (2021-2032)
- 2.3 Gatifloxacin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsule
- 2.3.3 Tablet
- 2.3.4 Aqueous Solution
- 2.3.5 Others
- 2.4 Gatifloxacin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Synthetic Antibacterial
- 2.4.3 Ophthalmic Medicine
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gatifloxacin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Gatifloxacin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Gatifloxacin Revenue of Manufacturers (2021-2026)
- 3.4 Global Gatifloxacin Average Price by Manufacturers (2021-2026)
- 3.5 Global Gatifloxacin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Gatifloxacin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Gatifloxacin, Product Type & Application
- 3.8 Global Manufacturers of Gatifloxacin, Established Date
- 3.9 Global Gatifloxacin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceuticals
- 4.1.1 Teva Pharmaceuticals Company Information
- 4.1.2 Teva Pharmaceuticals Business Overview
- 4.1.3 Teva Pharmaceuticals Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceuticals Gatifloxacin Product Portfolio
- 4.1.5 Teva Pharmaceuticals Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Gatifloxacin Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Gatifloxacin Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Pacific Pharma
- 4.4.1 Pacific Pharma Company Information
- 4.4.2 Pacific Pharma Business Overview
- 4.4.3 Pacific Pharma Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pacific Pharma Gatifloxacin Product Portfolio
- 4.4.5 Pacific Pharma Recent Developments
- 4.5 Lupin Pharmaceuticals
- 4.5.1 Lupin Pharmaceuticals Company Information
- 4.5.2 Lupin Pharmaceuticals Business Overview
- 4.5.3 Lupin Pharmaceuticals Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lupin Pharmaceuticals Gatifloxacin Product Portfolio
- 4.5.5 Lupin Pharmaceuticals Recent Developments
- 4.6 Hi Tech Pharmacal
- 4.6.1 Hi Tech Pharmacal Company Information
- 4.6.2 Hi Tech Pharmacal Business Overview
- 4.6.3 Hi Tech Pharmacal Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hi Tech Pharmacal Gatifloxacin Product Portfolio
- 4.6.5 Hi Tech Pharmacal Recent Developments
- 4.7 Bristol-Myers Squibb
- 4.7.1 Bristol-Myers Squibb Company Information
- 4.7.2 Bristol-Myers Squibb Business Overview
- 4.7.3 Bristol-Myers Squibb Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bristol-Myers Squibb Gatifloxacin Product Portfolio
- 4.7.5 Bristol-Myers Squibb Recent Developments
- 4.8 Apotex
- 4.8.1 Apotex Company Information
- 4.8.2 Apotex Business Overview
- 4.8.3 Apotex Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Apotex Gatifloxacin Product Portfolio
- 4.8.5 Apotex Recent Developments
- 4.9 Allergan
- 4.9.1 Allergan Company Information
- 4.9.2 Allergan Business Overview
- 4.9.3 Allergan Gatifloxacin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Allergan Gatifloxacin Product Portfolio
- 4.9.5 Allergan Recent Developments
5 Global Gatifloxacin Market Scenario by Region
- 5.1 Global Gatifloxacin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gatifloxacin Sales by Region: 2021-2032
- 5.2.1 Global Gatifloxacin Sales by Region: 2021-2026
- 5.2.2 Global Gatifloxacin Sales by Region: 2027-2032
- 5.3 Global Gatifloxacin Revenue by Region: 2021-2032
- 5.3.1 Global Gatifloxacin Revenue by Region: 2021-2026
- 5.3.2 Global Gatifloxacin Revenue by Region: 2027-2032
- 5.4 North America Gatifloxacin Market Facts & Figures by Country
- 5.4.1 North America Gatifloxacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Gatifloxacin Sales by Country (2021-2032)
- 5.4.3 North America Gatifloxacin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Gatifloxacin Market Facts & Figures by Country
- 5.5.1 Europe Gatifloxacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Gatifloxacin Sales by Country (2021-2032)
- 5.5.3 Europe Gatifloxacin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Gatifloxacin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Gatifloxacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Gatifloxacin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Gatifloxacin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Gatifloxacin Market Facts & Figures by Country
- 5.7.1 South America Gatifloxacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Gatifloxacin Sales by Country (2021-2032)
- 5.7.3 South America Gatifloxacin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Gatifloxacin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Gatifloxacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Gatifloxacin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Gatifloxacin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Gatifloxacin Sales by Type (2021-2032)
- 6.1.1 Global Gatifloxacin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Gatifloxacin Sales Market Share by Type (2021-2032)
- 6.2 Global Gatifloxacin Revenue by Type (2021-2032)
- 6.2.1 Global Gatifloxacin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Gatifloxacin Revenue Market Share by Type (2021-2032)
- 6.3 Global Gatifloxacin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Gatifloxacin Sales by Application (2021-2032)
- 7.1.1 Global Gatifloxacin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Gatifloxacin Sales Market Share by Application (2021-2032)
- 7.2 Global Gatifloxacin Revenue by Application (2021-2032)
- 7.2.1 Global Gatifloxacin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Gatifloxacin Revenue Market Share by Application (2021-2032)
- 7.3 Global Gatifloxacin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Gatifloxacin Value Chain Analysis
- 8.1.1 Gatifloxacin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Gatifloxacin Production Mode & Process
- 8.2 Gatifloxacin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Gatifloxacin Distributors
- 8.2.3 Gatifloxacin Customers
9 Global Gatifloxacin Analyzing Market Dynamics
- 9.1 Gatifloxacin Industry Trends
- 9.2 Gatifloxacin Industry Drivers
- 9.3 Gatifloxacin Industry Opportunities and Challenges
- 9.4 Gatifloxacin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst